Changes in pharmacokinetics and pharmacodynamics in the elderly patient

Journal of Pharmacy Practice

Volumn 20, Issue 1, 2007, Pages 4-12

  Hutchison, Lisa C ^a   O'Brien, Catherine E ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Aging; Drug dosage; Elderly; Pharmacodynamics; Pharmacokinetics

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; ALENDRONIC ACID; AMINOGLYCOSIDE; ATORVASTATIN; BENAZEPRILAT; BENZODIAZEPINE; CALCIUM CARBONATE; CEFTRIAXONE; CHLORDIAZEPOXIDE; CIMETIDINE; CIPROFLOXACIN; DIAZEPAM; DIGOXIN; FENTANYL; FLURAZEPAM; FUROSEMIDE; IBUPROFEN; ITRACONAZOLE; KETOCONAZOLE; LITHIUM; LORAZEPAM; NAPROXEN; PHENYTOIN; SALICYLIC ACID; TRIAZOLAM; UNINDEXED DRUG; VALPROIC ACID; WARFARIN;

ARTICLE; BIOAVAILABILITY; CARDIOVASCULAR RESPONSE; CENTRAL NERVOUS SYSTEM; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; ENTERIC COATED TABLET; ENZYME METABOLISM; GERIATRIC PATIENT; HUMAN; KIDNEY FUNCTION; LIQUID; LUNG FUNCTION; PATIENT CARE; PROTEIN BINDING; URINARY EXCRETION;

EID: 34547446159     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190007304657     Document Type: Article

References (49)

1. Greenblatt D., Harmatz J., Shader R. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part 1). Clin Pharmacokinet. 1991 ; 21: 165-177.
2. Merle L., Laroche M-L., Dantoine T., Charmes J-P. Predicting and preventing adverse drug reactions in the very old. Drugs Aging. 2005 ; 22: 375-392.
3. Hammerlein A., Derendorf H., Lowenthal DT Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications. Clin Pharmacokinet. 1998 ; 35: 49-64.
4. American Society of Consultant Pharmacists. The Silent Epidemic. Available at: http://www.ascp.com/consumers/tips/silentepidemic.cfm. Accessed January 5, 2007.
5. Lindblad CI, Gray SL, Guay Drp, Hajjar ER, McCarthy TC, Hanlon JT Geriatrics. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Physiologic Approach. 6 th ed. New York, NY: McGraw-Hill Companies ; 2005: 103-113.
6. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004 ; 56: 163-184.
7. Cusack BJ Pharmacokinetics in older persons. Am J Geriatr Pharmacother. 2004 ; 2: 274-302.
8. Bressler R., Bahl JJ Principles of drug therapy for the elderly patient. Mayo Clin Proc. 2003 ; 78: 1564-1577.
9. Grandison M., Boudinot F. Age-related changes in protein binding of drugs: implications for therapy. Clin Pharmacokinet. 2000 ; 38: 271-290.
10. Kinirons M., O'Mahony M. Drug metabolism and ageing. Br J Clin Pharmacol. 2004 ; 57: 540-544.
11. Lamb E., Webb M., Simpson D., Coakley A., Newman D., O'Riordan S. Estimation of glomerular filtration rate in older patients with chronic renal insufficiency: is the Modification of Diet in Renal Disease formula an improvement? J Am Geriatr Soc. 2003 ; 51: 1012-1017.
12. Cockroft D., Gault M. Prediction of creatinine-clearance from serum creatinine. Nephron. 1976 ; 15: 31-41.
13. Rigalleau V., Lasseur C., Perlemoine C., et al. Cockcroft-Gault formula is biased by body weight in diabetic patients with renal impairment. Metabolism. 2005 ; 55: 108-112.
14. Cirillo M., Anastasio P., De Santo NG Relationship of gender, age, and body mass index to errors in predicted kidney function. Nephrol Dial Transplant. 2005 ; 20: 1791-1798.
15. Brodde O., Leineweber K. Autonomic receptor systems in the failing and aging human heart: similarities and differences. Eur J Pharmacol. 2004 ; 500: 167-176.
16. Schutzer W., Mader S. Age-related changes in vascular adrenergic signaling: clinical and mechanistic implications. Ageing Res Rev. 2003 ; 2: 169-190.
17. Brodde O., Zerkowski H., Schranz D. Age-dependent changes in the beta-adrenerceptor-G-protein(s)-adenylyl cyclase system in human right atrium. J Cardiovasc Pharmacol. 1995 ; 26: 20-26.
18. Phillips P., Hodsman G., Johnston C. Neuroendocrine mechanisms and cardiovascular homeostasis in the elderly. Cardiovasc Drugs Ther. 1991 ; 4 (suppl 6). 1209-1213.
19. Mangoni A. Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations. Drugs Aging. 2005 ; 22: 913-941.
20. Benoit S., Mendelsohn A., Nourjah P., Staffa J., Graham D. Risk factors for prolonged QTc among US adults: third national health and nutrition examination survey. Eur J Cardiovasc Prev Rehabil. 2005 ; 12: 363-368.
21. Brodde O., Konschak U., Becker K. Cardiac muscarinic receptors decrease with age. in vitro and in vivo studies. J Clin Invest. 1998 ; 101: 471-478.
22. Giessler C., Wangemann T., Zerkowski H., Brodde O. Age-dependent decrease in the negative inotropic effect of carbachol on isolated human right atrium. Eur J Pharmacol. 1998 ; 357: 199-202.
23. Poller U., Nedelka G., Radke J., Ponicke K., Brodde O. Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers. J Am Coll Cardiol. 1997 ; 29: 187-193.
24. Parker A. Aging does not affect beta-agonist responsiveness after methacholine-induced bronchoconstriction. J Am Geriatr Soc. 2004 ; 52: 388-392.
25. Connolly M., Crowley J., Charan N., Nielson C., Vestal R. Impaired bronchodilator response to albuterol in healthy elderly men and women. Chest. 1995 ; 108: 401-406.
26. Ullah M., Newman G., Saunders K. Influence of age on response to ipratropium and salbutamol in asthma. Thorax. 1981 ; 36: 523-529.
27. Luckey A., Parsa C. Fluid and electrolytes in the aged. Arch Surg. 2003 ; 138: 1055-1060.
28. Blennow K., Gottfries C. Neurochemistry of aging. In: Nelson J, ed. Geriatric Psychopharmacology. New York, NY: Marcel Dekker Inc ; 1998: 1-25.
29. Blennow K., Fredman P., Wallin A., et al. Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. Eur Neurol. 1993 ; 33: 129-133.
30. Skoog I., Wallin A., Fredman P., et al. A population study on blood-brain barrier function in 85-year olds: relation to Alzheimer's disease and vascular dementia. Neurology. 1998 ; 50: 966-971.
31. Greenblatt D., Harmatz J., von Moltke L., Wright C, Shader R. Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate. Clin Pharmacol Ther. 2004 ; 76: 467-479.
32. Albrecht S., Ihmsen H., Hering W., et al. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Clin Pharmacol Ther. 1999 ; 65: 630-639.
33. Zubenko G., Sunderland T. Geriatric psychopharmacology: why does age matter? Harv Rev Psychiatry. 2000 ; 7: 311-333.
34. Gurwitz J., Avorn J., Ross-Degnan D., Choodnovskiy I., Ansell J. Aging and the anticoagulant response to warfarin therapy. Ann Intern Med. 1992 ; 116: 901-904.
35. Russmann S., Gohlke-Barwolf C., Jahnchen E., Trenk D., Roskamm H. Age-dependent differences in the anticoagulant effect of phenprocoumon in patients after heart valve surgery. Eur J Clin Pharmacol. 1997 ; 52: 31-35.
36. Balducci L., Hardy C., Lyman G. Hemopoietic reserve in the older cancer patient: clinical and economic considerations. Cancer Control. 2000 ; 7: 539-547.
37. Collins N., Shapiro R., Ramsay R. Elders with epilepsy. Med Clin North Am. 2006 ; 90: 945-966.
38. Bradley B. Rejection and recipient age. Transpl Immunol. 2002 ; 10: 125-132.
39. American Geriatrics Society. Two-step PPD Testing for Nursing Home Patients on Admission. AGS position paper. Available at: http://www. americangeriatrics.org/products/positionpapers/PPD-test.shtml. Accessed March 19, 2007.
40. Guslandi M., Pellegrini A., Sorghi M. Gastric mucosal defences in the elderly. Gerontology. 1999 ; 45: 206-208.
41. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999 ; 130: 461-470.
42. Levey A., Greene T., Kusek J., Beck G., Group MS A simplified equation to predict glomerular filtration rate from serum creatinine [abstract]. J Am Soc Nephrol. 2000 ; 11: 155A.
43. Laroche M-L., Charmes J-P., Marcheix A., Bouthier F., Merle L. Estimation of glomerular filtration rate in the elderly: Cockcroft-Gault versus Modification of Diet in Renal Disease formula. Pharmacotherapy. 2006 ; 26: 1041-1046.
44. Bailie GR, Uhlig K., Levey AS Clinical practice guidelines in nephrology: evaluation, classification and stratification of chronic kidney disease. Pharmacotherapy. 2005 ; 25 (4). 491-502.
45. Wolowich W., Raymo L., Rodriguez JC Problems with the use of the Modified Diet in Renal Disease Formula to estimate renal function. Pharmacotherapy. 2005 ; 25: 1283-1285.
46. Beers M., Ouslander J., Rollingher I., Reuben D., Brooks J., Beck J. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991 ; 151: 1825-1832.
47. Beers M. Explicit criteria for determining potentially inappropriate medication use by the elderly. an update. Arch Intern Med. 1997 ; 157: 1531-1536.
48. Fick D., Cooper J., Wade W., Waller J., Maclean J., Beers M. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003 ; 163: 2716-2724.
49. Wick J. The Beers Criteria: red flags for elders. Pharm Times. 2006: 56.